Metropolitan Life Insurance Company (MetLife)’s Synchronoss Technologies SNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-1,411
Closed -$38.7K – 2589
2020
Q1
$38.7K Buy
+1,411
New +$62.1K ﹤0.01% 2409
2019
Q4
– Sell
-489
Closed -$23.8K – 2557
2019
Q3
$23.8K Buy
489
+169
+53% +$11.5K ﹤0.01% 2543
2019
Q2
$22.8K Buy
+320
New +$18.1K ﹤0.01% 2592
2018
Q2
– Sell
-1,606
Closed -$152K – 2490
2018
Q1
$152K Buy
1,606
+217
+16% +$17.8K ﹤0.01% 2060
2017
Q4
$112K Sell
1,389
-1,781
-56% -$172K ﹤0.01% 2242
2017
Q3
$266K Hold
3,170
– – ﹤0.01% 2104
2017
Q2
$469K Hold
3,170
– – ﹤0.01% 1738
2017
Q1
$696K Hold
3,170
– – ﹤0.01% 1432
2016
Q4
$1.09M Sell
3,170
-80
-2% -$30.1K 0.01% 1250
2016
Q3
$1.2M Hold
3,250
– – 0.01% 1181
2016
Q2
$932K Buy
3,250
+39
+1% +$11.8K 0.01% 1298
2016
Q1
$935K Hold
3,211
– – 0.01% 1215
2015
Q4
$1.02M Buy
3,211
+266
+9% +$88.2K 0.01% 1180
2015
Q3
$869K Hold
2,945
– – 0.01% 1270
2015
Q2
$1.21M Sell
2,945
-96
-3% -$41.3K 0.01% 1167
2015
Q1
$1.3M Hold
3,041
– – 0.01% 1065
2014
Q4
$1.15M Hold
3,041
– – 0.01% 1245
2014
Q3
$1.25M Hold
3,041
– – 0.01% 1147
2014
Q2
$957K Buy
3,041
+555
+22% +$159K 0.01% 1380
2014
Q1
$767K Hold
2,486
– – 0.01% 1525
2013
Q4
$695K Hold
2,486
– – ﹤0.01% 1578
2013
Q3
$852K Sell
2,486
-116
-4% -$35.3K 0.01% 1378
2013
Q2
$723K Buy
+2,602
New +$700K 0.01% 1452

Other funds holding SNCR

Metropolitan Life Insurance Company (MetLife)'s SNCR Position: Q2 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Synchronoss Technologies (SNCR) in Q2 2020, closing a stake of 1,411 shares — an estimated $38.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SNCR in Q2 2013 and held it in 23 quarters. The position peaked at $1.3M in Q1 2015. 82 funds tracked by Wall St. Rank hold SNCR as of Q2 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Synchronoss Technologies position as of Q2 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,411 Synchronoss Technologies shares in Q2 2020, an estimated $38.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Synchronoss Technologies in Q2 2013 and held it in 23 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Synchronoss Technologies position peaked at $1.3M in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Synchronoss Technologies as of Q2 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.